Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 10, 2025
Analysis of a Modified Version of the Inventory of Non-Ataxia Signs Over 12 Years in Patients with Friedreich's Ataxia in the EFACTS Study
Stella Andrea Lischewski, Imis Dogan, Paola Giunti, et al.
Neurobiology of Disease
|
February 7, 2026
Cognitive impairment in SCA3: A multi-center cohort study with demographic, imaging, and biomarker correlates
Roderick P P W M Maas, Hector Garcia-Moreno, Jennifer Faber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 16, 2021
Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood
Jeannette Hübener-Schmid, Kirsten Kuhlbrodt, Julien Peladan, et al.
Journal of Neurology
|
April 17, 2025
Optimizing selectivity of the Cerebellar Cognitive Affective Syndrome Scale by use of correction formulas, and validation of its German version
Andreas Thieme, Kerstin Rubarth, Raquel van der Veen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 29, 2021
Characterization of Lifestyle in Spinocerebellar Ataxia Type 3 and Association with Disease Severity
Holger Hengel, Peter Martus, Jennifer Faber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 9, 2022
Differential Temporal Dynamics of Axial and Appendicular Ataxia in SCA3
Roderick P P W M Maas, Steven Teerenstra, Manuela Lima, et al.
CNS Drugs
|
October 17, 2025
The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI Cohort
Patrick Silva, Marina A Costa, Laetitia Gaspar, et al.
The Lancet. Neurology
|
May 28, 2013
Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data
Heike Jacobi, Kathrin Reetz, Sophie Tezenas du Montcel, et al.
The Lancet. Neurology
|
August 22, 2020
Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study
Heike Jacobi, Sophie Tezenas du Montcel, Sandro Romanzetti, et al.
Journal of Neurology
|
November 3, 2022
The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors
Holger Hengel, Peter Martus, Jennifer Faber, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 10, 2025
Analysis of a Modified Version of the Inventory of Non-Ataxia Signs Over 12 Years in Patients with Friedreich's Ataxia in the EFACTS Study
Stella Andrea Lischewski, Imis Dogan, Paola Giunti, et al.
Neurobiology of Disease
|
February 7, 2026
Cognitive impairment in SCA3: A multi-center cohort study with demographic, imaging, and biomarker correlates
Roderick P P W M Maas, Hector Garcia-Moreno, Jennifer Faber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 16, 2021
Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood
Jeannette Hübener-Schmid, Kirsten Kuhlbrodt, Julien Peladan, et al.
Journal of Neurology
|
April 17, 2025
Optimizing selectivity of the Cerebellar Cognitive Affective Syndrome Scale by use of correction formulas, and validation of its German version
Andreas Thieme, Kerstin Rubarth, Raquel van der Veen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 29, 2021
Characterization of Lifestyle in Spinocerebellar Ataxia Type 3 and Association with Disease Severity
Holger Hengel, Peter Martus, Jennifer Faber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 9, 2022
Differential Temporal Dynamics of Axial and Appendicular Ataxia in SCA3
Roderick P P W M Maas, Steven Teerenstra, Manuela Lima, et al.
CNS Drugs
|
October 17, 2025
The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI Cohort
Patrick Silva, Marina A Costa, Laetitia Gaspar, et al.
The Lancet. Neurology
|
May 28, 2013
Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data
Heike Jacobi, Kathrin Reetz, Sophie Tezenas du Montcel, et al.
The Lancet. Neurology
|
August 22, 2020
Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study
Heike Jacobi, Sophie Tezenas du Montcel, Sandro Romanzetti, et al.
Journal of Neurology
|
November 3, 2022
The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors
Holger Hengel, Peter Martus, Jennifer Faber, et al.
Page
of 7